Dear colleagues, hello! 👋
Let’s Talk Risk! is celebrating our 1st birthday 🎂🙌! Thank you for our support and continued engagement! I am looking forward to continuing our journey of shared learning this year. Please reach out anytime if you have any feedback or suggestions to enhance your learning experience on LTR.
A special welcome to 130+ new members who have joined our Let’s Talk Risk! community in the month of February! Feel free to browse past articles in the archive section of the Let’s Talk Risk! website, and check out recordings of recent LTR conversations in the podcast section.
Here are links to articles published this week.
Announcements
Special promotion - save 20% on annual subscription for full access to premium content on LTR
If you would like to upgrade your subscription for full access to premium content such as case studies, monthly webinars and exclusive podcasts, take advantage of this special promotional offer!
Note: this offer expires on Mar 8, 2024
LTR weekly conversation on LinkedIn: how to succeed in a risk management role.
Join me next Friday, March 8, 2024 at 11:00 AM EST, for another Let’s Talk Risk! conversation on LinkedIn. My guest this week is Carolyn (Beres) Blandford who will share tips for success in a risk management role.
Pre-registration is now open for the next session of Live ISO 14971 training on ACHIEVE. Paid subscribers get 20% off regular price!
Save your spot here to join the next cohort of the LIVE ISO 14971 certification training course starting in March 2024. Watch a course introduction video and check out testimonials from past attendees!
Weekly Knowledge Challenge
I hope you enjoyed the knowledge challenge question last week. Here is the correct answer:
The correct answer for the question, “According to the final rule on the Quality Management System Regulation (QMSR) FDA does not have the authority to review the contents of Management Review or Internal Audit reports.” is False.
LTR Weekly Digest #26 - 2nd March, 2024